Literature DB >> 32073531

Severe Late-Onset Kawasaki Disease Successfully Treated With Anakinra.

Gauthier Blonz1, Sylvie Lacroix, Nadir Benbrik, Karine Warin-Fresse, Agathe Masseau, David Trewick, Mohamed Hamidou, Jean-Louis Stephan, Antoine Néel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32073531     DOI： 10.1097/RHU.0000000000000814

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  14 in total

1.  NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis.

Authors:  Rebecca A Porritt; David Zemmour; Masanori Abe; Moshe Arditi; Magali Noval Rivas; Youngho Lee; Meena Narayanan; Thacyana T Carvalho; Angela C Gomez; Daisy Martinon; Chintda Santiskulvong; Michael C Fishbein; Shuang Chen; Timothy R Crother; Kenichi Shimada
Journal:  Circ Res       Date:  2021-09-14       Impact factor: 23.213

2.  A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.

Authors:  Priya R Soni; Magali Noval Rivas; Moshe Arditi
Journal:  Curr Rheumatol Rep       Date:  2020-02-05       Impact factor: 4.686

Review 3.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

4.  Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra.

Authors:  Alessandro Gambacorta; Danilo Buonsenso; Gabriella De Rosa; Ilaria Lazzareschi; Antonio Gatto; Federica Brancato; Davide Pata; Piero Valentini
Journal:  Front Pediatr       Date:  2020-05-07       Impact factor: 3.418

Review 5.  Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Authors:  Alessandra Bettiol; Giuseppe Lopalco; Giacomo Emmi; Luca Cantarini; Maria Letizia Urban; Antonio Vitale; Nunzio Denora; Antonio Lopalco; Annalisa Cutrignelli; Angela Lopedota; Vincenzo Venerito; Marco Fornaro; Alfredo Vannacci; Donato Rigante; Rolando Cimaz; Florenzo Iannone
Journal:  Int J Mol Sci       Date:  2019-04-17       Impact factor: 5.923

Review 6.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 7.  Anakinra Therapy for Non-cancer Inflammatory Diseases.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

8.  Complete Regression of Giant Aneurysms in an Infant with Delayed Diagnosis and Refractory Kawasaki Disease via Combination Anticytokine Therapy: Case Report and Review of Similar Cases.

Authors:  Maegan Williams; Lakshmi Nagaraju; Mark Gorelik
Journal:  Case Rep Rheumatol       Date:  2020-03-28

Review 9.  Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.

Authors:  Giovanna Ferrara; Teresa Giani; Maria Costanza Caparello; Carla Farella; Lisa Gamalero; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2020-12       Impact factor: 3.022

Review 10.  The off-label use of anakinra in pediatric systemic autoinflammatory diseases.

Authors:  Valerio Maniscalco; Sarah Abu-Rumeileh; Maria Vincenza Mastrolia; Edoardo Marrani; Ilaria Maccora; Ilaria Pagnini; Gabriele Simonini
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-10-16       Impact factor: 5.346
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.